This study investigates the therapeutic potential of microbiome-targeted interventions for moderate-to-severe atopic dermatitis through a comprehensive clinical trial evaluating both skin and gut microbiome modulation. The randomized controlled study compared three treatment approaches: oral probiotic supplementation, topical application of commensal skin bacteria, and a combination of both therapies, against standard care in 65 patients over 12 weeks. Clinical assessments demonstrated superior
No takes yet. Share an insight, caveat, or question.
Isaev et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: